|
DE602007009128D1
(de)
|
2006-07-10 |
2010-10-21 |
Paion Uk Ltd |
Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon
|
|
KR20120097508A
(ko)
*
|
2009-11-05 |
2012-09-04 |
글락소스미스클라인 엘엘씨 |
벤조디아제핀 브로모도메인 억제제
|
|
JP5715241B2
(ja)
*
|
2010-05-14 |
2015-05-07 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法
|
|
CA2799381A1
(en)
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Male contraceptive compositions and methods of use
|
|
US8981083B2
(en)
|
2010-05-14 |
2015-03-17 |
Dana Farber Cancer Institute, Inc. |
Compositions and methods for treating neoplasia, inflammatory disease and other disorders
|
|
MX373121B
(es)
|
2010-05-14 |
2020-04-30 |
Dana Farber Cancer Inst Inc |
Composiciones y metodos para el tratamiento de leucemia.
|
|
EP2450039A1
(en)
|
2010-11-08 |
2012-05-09 |
PAION UK Ltd. |
Dosing regimen for sedation with CNS 7056 (Remimazolam)
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
WO2012151512A2
(en)
|
2011-05-04 |
2012-11-08 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
US9328117B2
(en)
|
2011-06-17 |
2016-05-03 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
GB201114103D0
(en)
*
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2013033270A2
(en)
*
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
|
|
DE102011082013A1
(de)
*
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
CA2870931A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Isoindolone derivatives
|
|
GEAP201813666A
(en)
*
|
2012-05-22 |
2018-01-25 |
Paion Uk Ltd |
Compositions comprising short-acting benzodiazepines
|
|
US9624244B2
(en)
|
2012-06-06 |
2017-04-18 |
Constellation Pharmaceuticals, Inc. |
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
TWI602820B
(zh)
|
2012-06-06 |
2017-10-21 |
星宿藥物公司 |
溴域抑制劑及其用途
|
|
AU2012382373A1
(en)
|
2012-06-12 |
2014-12-11 |
Abbvie Inc. |
Pyridinone and pyridazinone derivatives
|
|
CN104582708A
(zh)
*
|
2012-08-16 |
2015-04-29 |
葛兰素史克有限责任公司 |
用于治疗小细胞肺癌的苯并二氮*类
|
|
CA2881996A1
(en)
|
2012-08-16 |
2014-02-20 |
Bayer Pharma Aktiengesellschaft |
2,3-benzodiazepines
|
|
EP2900672B1
(de)
|
2012-09-28 |
2017-02-22 |
Bayer Pharma Aktiengesellschaft |
Bet-proteininhibitorische 5-aryl-triazolo-azepine
|
|
WO2014096965A2
(en)
|
2012-12-21 |
2014-06-26 |
Rvx Therapeutics Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
AR094963A1
(es)
|
2013-03-04 |
2015-09-09 |
Ono Pharmaceutical Co |
Reacción de oxidación excelente en el índice de conversión
|
|
EP2970312B1
(en)
|
2013-03-11 |
2017-11-15 |
The Regents of The University of Michigan |
Bet bromodomain inhibitors and therapeutic methods using the same
|
|
MX2015012158A
(es)
*
|
2013-03-11 |
2015-12-01 |
Abbvie Inc |
Inhibidores de bomodominio tetraciclicos fusionados.
|
|
WO2014139324A1
(en)
*
|
2013-03-12 |
2014-09-18 |
Abbvie Inc. |
Tetracyclic bromodomain inhibitors
|
|
CN105407894A
(zh)
|
2013-03-14 |
2016-03-16 |
康威基内有限公司 |
用于抑制含布罗莫结构域的蛋白质的方法和组合物
|
|
US9714946B2
(en)
|
2013-03-14 |
2017-07-25 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
MX366703B
(es)
|
2013-03-15 |
2019-07-22 |
Incyte Holdings Corp |
Heterociclos tricíclicos como inhibidores de la proteína bet.
|
|
CA2901083A1
(en)
|
2013-04-26 |
2014-10-30 |
Beigene, Ltd. |
Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
|
|
CN104146970A
(zh)
*
|
2013-05-05 |
2014-11-19 |
王元青 |
治疗精神疾病的冻干粉针剂
|
|
CN103202815B
(zh)
*
|
2013-05-05 |
2014-09-24 |
李友香 |
治疗精神疾病的注射剂
|
|
WO2015004533A2
(en)
|
2013-06-21 |
2015-01-15 |
Zenith Epigenetics Corp. |
Novel substituted bicyclic compounds as bromodomain inhibitors
|
|
SG11201510409QA
(en)
|
2013-06-21 |
2016-01-28 |
Zenith Epigenetics Corp |
Novel bicyclic bromodomain inhibitors
|
|
WO2015006193A1
(en)
|
2013-07-08 |
2015-01-15 |
Incyte Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
|
WO2015015318A2
(en)
|
2013-07-31 |
2015-02-05 |
Zenith Epigenetics Corp. |
Novel quinazolinones as bromodomain inhibitors
|
|
KR20160072261A
(ko)
|
2013-11-08 |
2016-06-22 |
다나-파버 캔서 인스티튜트 인크. |
브로모도메인 및 엑스트라-말단 (bet) 단백질 저해제를 이용한 암 치료를 위한 조합 요법
|
|
US9315501B2
(en)
|
2013-11-26 |
2016-04-19 |
Incyte Corporation |
Bicyclic heterocycles as BET protein inhibitors
|
|
WO2015081203A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
GB201320994D0
(en)
*
|
2013-11-28 |
2014-01-15 |
Univ Dundee |
Enzyme function probes
|
|
US9309246B2
(en)
|
2013-12-19 |
2016-04-12 |
Incyte Corporation |
Tricyclic heterocycles as BET protein inhibitors
|
|
KR20160111036A
(ko)
|
2014-01-31 |
2016-09-23 |
다나-파버 캔서 인스티튜트 인크. |
디아제판 유도체 및 그의 용도
|
|
MX2016009974A
(es)
|
2014-01-31 |
2016-10-31 |
Dana Farber Cancer Inst Inc |
Derivados de diaminopirimidina bencensulfona y sus usos.
|
|
WO2015117087A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
JP6526060B2
(ja)
|
2014-02-10 |
2019-06-05 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換トリアゾロベンゾジアゼピン
|
|
US9580430B2
(en)
|
2014-02-28 |
2017-02-28 |
The Regents Of The University Of Michigan |
9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors
|
|
RU2722179C2
(ru)
|
2014-02-28 |
2020-05-28 |
Тэнша Терапеутикс, Инк. |
Лечение состояний, ассоциированных с гиперинсулинемией
|
|
US9884874B2
(en)
|
2014-04-09 |
2018-02-06 |
Kainos Medicine, Inc. |
Bromodomain-inhibiting compounds and pharmaceutical composition comprising same for preventing or treating a cancer
|
|
UA119870C2
(uk)
|
2014-04-23 |
2019-08-27 |
Інсайт Корпорейшн |
1H-ПІРОЛО[2,3-c]ПІРИДИН-7(6H)-ОНИ ТА ПІРАЗОЛО[3,4-c]ПІРИДИН-7(6H)-ОНИ ЯК ІНГІБІТОРИ БІЛКІВ BET
|
|
CA2952526A1
(en)
*
|
2014-06-18 |
2015-12-23 |
Bayer Pharma Aktiengesellschaft |
Bet-protein inhibiting 3,4-dihydropyrido[2,3-b]pyrazinones with meta-substituted aromatic amino- or ether groups
|
|
CN106687463B
(zh)
|
2014-06-20 |
2019-04-09 |
星座制药公司 |
一种乙酰胺类化合物的晶型
|
|
WO2016022970A1
(en)
|
2014-08-08 |
2016-02-11 |
Dana-Farber Cancer Institute, Inc. |
Dihydropteridinone derivatives and uses thereof
|
|
EP3177626A4
(en)
|
2014-08-08 |
2017-12-27 |
Dana Farber Cancer Institute, Inc. |
Diazepane derivatives and uses thereof
|
|
ES2855225T3
(es)
|
2014-09-15 |
2021-09-23 |
Incyte Corp |
Heterociclos tricíclicos para su uso como inhibidores de proteínas BET
|
|
BR112017006342A2
(pt)
|
2014-10-02 |
2017-12-19 |
Glaxosmithkline Ip No 2 Ltd |
composto de sal de ácido benzenossulfônico, forma em estado sólido cristalino, composição farmacêutica, produto farmacêutico de combinação, método de tratamento de doenças ou condições, uso de um composto de sal de ácido benzenossulfônico, e, processo para preparação de um composto de sal de ácido benzenossulfônico.
|
|
UA122130C2
(uk)
|
2014-10-27 |
2020-09-25 |
Тенша Терапеутікс, Інк. |
Інгібітори бромодомену
|
|
US10208081B2
(en)
|
2014-11-26 |
2019-02-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
US10710992B2
(en)
|
2014-12-01 |
2020-07-14 |
Zenith Epigenetics Ltd. |
Substituted pyridinones as bromodomain inhibitors
|
|
EP3227280B1
(en)
|
2014-12-01 |
2019-04-24 |
Zenith Epigenetics Ltd. |
Substituted pyridines as bromodomain inhibitors
|
|
JP2017537946A
(ja)
|
2014-12-11 |
2017-12-21 |
ゼニス・エピジェネティクス・リミテッドZenith Epigenetics Ltd. |
ブロモドメイン阻害剤としての置換複素環
|
|
HK1245247A1
(zh)
|
2014-12-17 |
2018-08-24 |
恒翼生物医药科技(上海)有限公司 |
溴结构域的抑制剂
|
|
WO2016138332A1
(en)
|
2015-02-27 |
2016-09-01 |
The Regents Of The University Of Michigan |
9h-pyrimido [4,5-b] indoles as bet bromodomain inhibitors
|
|
GB201504694D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Covalent conjugates
|
|
SI3277286T1
(sl)
|
2015-03-31 |
2021-09-30 |
Enanta Pharmaceuticals, Inc. |
Derivati žolčne kisline kot antagonisti FXR/TGR5 in metode za njihovo uporabo
|
|
WO2016171470A1
(en)
*
|
2015-04-21 |
2016-10-27 |
Kainos Medicine, Inc. |
Bromodomain-inhibiting compounds and methods to prevent or treat a cancer
|
|
WO2016196065A1
(en)
|
2015-05-29 |
2016-12-08 |
Genentech, Inc. |
Methods and compositions for assessing responsiveness of cancers to bet inhibitors
|
|
US10702527B2
(en)
|
2015-06-12 |
2020-07-07 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
WO2016203335A1
(en)
|
2015-06-18 |
2016-12-22 |
Pfizer Inc. |
Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
|
|
AU2016283020A1
(en)
|
2015-06-26 |
2018-01-04 |
Tensha Therapeutics, Inc. |
Treatment of nut midline carcinoma
|
|
JP6765622B2
(ja)
*
|
2015-07-17 |
2020-10-07 |
日本光電工業株式会社 |
救命支援装置
|
|
AU2016297024B2
(en)
|
2015-07-22 |
2021-03-04 |
Enanta Pharmaceuticals, Inc. |
Benzodiazepine derivatives as RSV inhibitors
|
|
US11306105B2
(en)
|
2015-09-11 |
2022-04-19 |
Dana-Farber Cancer Institute, Inc. |
Cyano thienotriazolodiazepines and uses thereof
|
|
JP2018526424A
(ja)
|
2015-09-11 |
2018-09-13 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
アセトアミドチエノトリアゾロジアゼピンおよびこれらの使用
|
|
TW201722966A
(zh)
|
2015-10-29 |
2017-07-01 |
英塞特公司 |
Bet蛋白質抑制劑之非晶固體形式
|
|
CR20180336A
(es)
|
2015-11-25 |
2018-08-06 |
Dana Farber Cancer Inst Inc |
Inhibidores de bromodominio bivalentes y usos de los mismos
|
|
CN106892924B
(zh)
*
|
2015-12-17 |
2021-01-08 |
四川科伦博泰生物医药股份有限公司 |
短效苯并二氮*衍生物、其制备方法及其用途
|
|
EP3402799B1
(en)
|
2016-01-15 |
2022-05-04 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as rsv inhibitors
|
|
ES2882066T3
(es)
|
2016-02-15 |
2021-12-01 |
Univ Michigan Regents |
1,4-oxazepinas fusionadas y análogos relacionados como inhibidores de bromodominio BET
|
|
CN113788818A
(zh)
|
2016-04-06 |
2021-12-14 |
密执安大学评议会 |
Mdm2蛋白质降解剂
|
|
AU2017246453A1
(en)
|
2016-04-06 |
2018-11-08 |
The Regents Of The University Of Michigan |
Monofunctional intermediates for ligand-dependent target protein degradation
|
|
BR112018070859A2
(pt)
|
2016-04-12 |
2019-02-05 |
Univ Michigan Regents |
degradantes da proteína de bet
|
|
RS60302B1
(sr)
|
2016-04-15 |
2020-07-31 |
Abbvie Inc |
Inhibitori bromodomena
|
|
US10080742B2
(en)
|
2016-04-26 |
2018-09-25 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as FXR agonists and methods of use thereof
|
|
WO2017189663A1
(en)
|
2016-04-26 |
2017-11-02 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
WO2017189652A1
(en)
|
2016-04-26 |
2017-11-02 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
DE102017005091A1
(de)
|
2016-05-30 |
2017-11-30 |
Bayer Pharma Aktiengesellschaft |
Substituierte 3,4-Dihydropyrido[2,3-b]pyrazin-2(1H)-one
|
|
DE102017005089A1
(de)
|
2016-05-30 |
2017-11-30 |
Bayer Pharma Aktiengesellschaft |
Substitulerte 3,4-Dihydrochinoxalin-2(1H)-one
|
|
AU2017281286B2
(en)
|
2016-06-20 |
2021-05-20 |
Incyte Corporation |
Crystalline solid forms of a bet inhibitor
|
|
CN107629057B
(zh)
*
|
2016-07-19 |
2020-03-27 |
上海勋和医药科技有限公司 |
Bet蛋白抑制剂及其应用
|
|
US10918647B2
(en)
|
2016-07-26 |
2021-02-16 |
University Of Southern California |
Selective bromodomain inhibition of fungal Bdf1
|
|
US10975093B2
(en)
|
2016-09-13 |
2021-04-13 |
The Regents Of The University Of Michigan |
Fused 1,4-diazepines as BET protein degraders
|
|
CN110062759B
(zh)
|
2016-09-13 |
2022-05-24 |
密执安大学评议会 |
作为bet蛋白降解剂的稠合的1,4-氧氮杂䓬
|
|
EP3523298A4
(en)
|
2016-10-04 |
2020-06-24 |
Enanta Pharmaceuticals, Inc. |
ISOXAZOLANALOGA AS FXR AGONISTS AND METHOD FOR USE THEREOF
|
|
US10597391B2
(en)
|
2016-10-26 |
2020-03-24 |
Enanta Pharmaceuticals, Inc. |
Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof
|
|
JP2019534306A
(ja)
|
2016-11-10 |
2019-11-28 |
羅欣薬業(上海)有限公司Luoxin Pharmaceutical(Shanghai) Co., Ltd. |
窒素含有大員環系化合物、その製造方法、薬物組成物および使用
|
|
WO2018129287A1
(en)
*
|
2017-01-06 |
2018-07-12 |
Enanta Pharmaceuticals, Inc. |
Heteroaryldiazepine derivatives as rsv inhibitors
|
|
WO2018144789A1
(en)
|
2017-02-03 |
2018-08-09 |
The Regents Of The University Of Michigan |
Fused 1,4-diazepines as bet bromodomain inhibitors
|
|
AU2018221820B2
(en)
|
2017-02-16 |
2023-11-02 |
Enanta Pharmaceuticals, Inc. |
Processes for the preparation of benzodiazepine derivatives
|
|
CN108727380A
(zh)
*
|
2017-04-13 |
2018-11-02 |
中国科学院上海药物研究所 |
一种brd4抑制剂及其制备和应用
|
|
CN110418791B
(zh)
*
|
2017-04-28 |
2022-07-01 |
四川科伦博泰生物医药股份有限公司 |
包含苯并二氮䓬类化合物的注射用组合物及其制备方法
|
|
CN108948018B
(zh)
*
|
2017-05-17 |
2021-03-30 |
四川科伦博泰生物医药股份有限公司 |
苯并二氮*衍生物及其盐和相关晶体形式、制备方法和用途
|
|
WO2018226801A1
(en)
|
2017-06-07 |
2018-12-13 |
Enanta Pharmaceuticals, Inc. |
Aryldiazepine derivatives as rsv inhibitors
|
|
WO2019006291A1
(en)
|
2017-06-30 |
2019-01-03 |
Enanta Pharmaceuticals, Inc. |
HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
|
|
WO2019006295A1
(en)
|
2017-06-30 |
2019-01-03 |
Enanta Pharmaceuticals, Inc. |
HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
|
|
WO2019055444A1
(en)
|
2017-09-13 |
2019-03-21 |
The Regents Of The University Of Michigan |
DEGRADATION AGENTS OF BROMODOMAIN BET PROTEIN WITH CLEAR BINDERS
|
|
US11312726B2
(en)
*
|
2017-09-22 |
2022-04-26 |
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
Thienodiazepine derivatives and application thereof
|
|
WO2019067864A1
(en)
|
2017-09-29 |
2019-04-04 |
Enanta Pharmaceuticals, Inc. |
PHARMACEUTICAL AGENTS IN COMBINATION AS INHIBITORS OF RSV
|
|
WO2019094920A1
(en)
|
2017-11-13 |
2019-05-16 |
Enanta Pharmaceuticals, Inc. |
Azepin-2-one derivatives as rsv inhibitors
|
|
MX394621B
(es)
|
2017-11-13 |
2025-03-24 |
Enanta Pharm Inc |
Procesos para la resolucion de los derivados de la benzodiazepina-2-ona y de la benzoazepin-2-ona
|
|
US10689391B2
(en)
|
2017-12-12 |
2020-06-23 |
Enanta Pharmaceuticals, Inc. |
Isoxazole analogs as FXR agonists and methods of use thereof
|
|
WO2019160813A1
(en)
|
2018-02-14 |
2019-08-22 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as fxr agonists and methods of use thereof
|
|
US10975094B2
(en)
|
2018-04-11 |
2021-04-13 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as RSV inhibitors
|
|
EP4342543A3
(en)
|
2018-09-11 |
2024-06-19 |
F. Hoffmann-La Roche AG |
Tert-butyl (s)-2-(4-(phenyl)-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a] [1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain brd4 inhibitors for treating cancer
|
|
US20220177490A1
(en)
*
|
2019-03-07 |
2022-06-09 |
Medshine Discovery Inc. |
Compounds having both effects of bet bromodomain protein inhibition and pd-l1 gene regulation
|
|
JP7558189B2
(ja)
|
2019-03-18 |
2024-09-30 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
Rsv阻害剤としてのベンゾジアゼピン誘導体
|
|
US11179400B2
(en)
|
2019-04-09 |
2021-11-23 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as RSV inhibitors
|
|
GB201905721D0
(en)
|
2019-04-24 |
2019-06-05 |
Univ Dundee |
Compounds
|
|
US11555032B2
(en)
|
2019-05-13 |
2023-01-17 |
Enanta Pharmaceuticals, Inc. |
Isoxazole derivatives as FXR agonists and methods of use thereof
|
|
CA3153297A1
(en)
|
2019-10-04 |
2021-04-08 |
Adam SZYMANIAK |
Antiviral heterocyclic compounds
|
|
US11505558B1
(en)
|
2019-10-04 |
2022-11-22 |
Enanta Pharmaceuticals, Inc. |
Antiviral heterocyclic compounds
|
|
PT116050B
(pt)
*
|
2020-01-09 |
2022-06-15 |
Hovione Farm S A |
Conjugados fármaco-ligando e inibidores das proteínas da família bromodomínio e domínio extraterminal -(bet) modificados
|
|
UY39032A
(es)
|
2020-01-24 |
2021-07-30 |
Enanta Pharm Inc |
Compuestos heterocíclicos como agentes antivirales
|
|
WO2021175432A1
(en)
|
2020-03-04 |
2021-09-10 |
Boehringer Ingelheim International Gmbh |
Method for administration of an anti cancer agent
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
KR20230026461A
(ko)
|
2020-06-23 |
2023-02-24 |
제넨테크, 인크. |
거대고리 화합물 및 이의 사용 방법
|
|
US11534439B2
(en)
|
2020-07-07 |
2022-12-27 |
Enanta Pharmaceuticals, Inc. |
Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
|
|
US11945824B2
(en)
|
2020-10-19 |
2024-04-02 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as anti-viral agents
|
|
GB202016977D0
(en)
|
2020-10-26 |
2020-12-09 |
In4Derm Ltd |
Compounds
|
|
CN114456171A
(zh)
*
|
2020-11-09 |
2022-05-10 |
中国药科大学 |
一类用于镇静催眠的苯并二氮䓬类药物、其制备方法及应用
|
|
CN112358483A
(zh)
*
|
2020-11-09 |
2021-02-12 |
中国药科大学 |
一类新型苯并二氮*类化合物、其制备方法及其用途
|
|
WO2022182861A1
(en)
|
2021-02-26 |
2022-09-01 |
Enanta Pharmaceuticals, Inc. |
Antiviral heterocyclic compounds
|
|
US20240308998A1
(en)
|
2021-06-29 |
2024-09-19 |
Tay Therapeutics Limited |
Pyrrolopyridone derivatives useful in the treatment of cancer
|
|
AR129003A1
(es)
|
2022-04-07 |
2024-07-03 |
Enanta Pharm Inc |
Compuestos heterocíclicos antivirales
|
|
CN119365455A
(zh)
|
2022-04-19 |
2025-01-24 |
纽韦卢森公司 |
对溴结构域有活性的化合物
|
|
WO2023211997A1
(en)
|
2022-04-27 |
2023-11-02 |
Enanta Pharmaceuticals, Inc. |
Antiviral compounds
|
|
EP4558224A1
(en)
|
2022-07-21 |
2025-05-28 |
Tay Therapeutics Limited |
Pyrroles and imidazoles as bet protein inhibitors
|